$1.43 Billion is the total value of Slate Path Capital LP's 15 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 45.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $171,069,000 | – | 2,245,000 | +100.0% | 11.97% | – |
| TRCO | New | TRIBUNE MEDIA COcl a | $162,276,000 | – | 2,715,000 | +100.0% | 11.35% | – |
| CHTR | CHARTER COMMUNICATIONS INC Dcl a new | $151,624,000 | +10.1% | 910,000 | 0.0% | 10.61% | +71.2% | |
| TSO | Buy | TESORO CORP | $134,945,000 | +109.8% | 1,815,000 | +72.0% | 9.44% | +226.2% |
| IWM | Sell | ISHARES TRput | $119,620,000 | -27.1% | 1,000,000 | -33.3% | 8.37% | +13.4% |
| SIRI | Buy | SIRIUS XM HLDGS INC | $115,535,000 | +14.4% | 33,010,000 | +14.1% | 8.08% | +77.9% |
| MPC | Buy | MARATHON PETE CORP | $109,666,000 | +25.7% | 1,215,000 | +18.0% | 7.67% | +95.6% |
| P | Buy | PANDORA MEDIA INC | $100,847,000 | -18.2% | 5,656,054 | +10.8% | 7.06% | +27.2% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $82,935,000 | +24.2% | 855,000 | 0.0% | 5.80% | +93.1% | |
| IPXL | IMPAX LABORATORIES INC | $73,814,000 | +33.6% | 2,330,000 | 0.0% | 5.16% | +107.8% | |
| ZNGA | Buy | ZYNGA INCcl a | $69,532,000 | +12.9% | 26,140,000 | +14.6% | 4.86% | +75.7% |
| YOKU | Buy | YOUKU TUDOU INCsponsored adr | $56,814,000 | +15.1% | 3,190,000 | +15.8% | 3.98% | +79.0% |
| GOLD | Sell | BARRICK GOLD CORP | $42,624,000 | -58.6% | 3,965,000 | -43.6% | 2.98% | -35.6% |
| MDCO | Sell | MEDICINES CO | $19,077,000 | -20.5% | 689,455 | -35.9% | 1.34% | +23.7% |
| AIG | Sell | AMERICAN INTL GROUP INC | $19,043,000 | -82.0% | 340,000 | -82.7% | 1.33% | -72.0% |
| CLF | Exit | CLIFFS NAT RES INC | $0 | – | -855,000 | -100.0% | -0.40% | – |
| TPUB | Exit | TRIBUNE PUBG CO | $0 | – | -506,531 | -100.0% | -0.46% | – |
| PBF | Exit | PBF ENERGY INCcl a | $0 | – | -1,420,000 | -100.0% | -1.53% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -190,000 | -100.0% | -3.95% | – |
| WAG | Exit | WALGREEN CO | $0 | – | -2,245,000 | -100.0% | -5.98% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,500,000 | -100.0% | -13.29% | – |
| DIA | Exit | SPDR DOW JONES INDL AVRG ETFput | $0 | – | -3,000,000 | -100.0% | -22.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.